- Home
- DTIL vs PCF Comparison
DTIL vs PCF Comparison
Compare DTIL & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | PCF |
|---|---|---|
| Founded | 2006 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.0M | 116.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | DTIL | PCF |
|---|---|---|
| Price | $4.99 | $6.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $47.00 | N/A |
| AVG Volume (30 Days) | ★ 198.7K | 74.8K |
| Earning Date | 11-03-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.90% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $698,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $34.30 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.61 | $5.71 |
| 52 Week High | $8.82 | $6.96 |
Technical Indicators
Market Signals| Indicator | DTIL | PCF |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 34.76 |
| Support Level | $4.61 | $6.23 |
| Resistance Level | $5.20 | $6.28 |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 41.08 | 10.53 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.